<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00915759</url>
  </required_header>
  <id_info>
    <org_study_id>08-6961</org_study_id>
    <nct_id>NCT00915759</nct_id>
  </id_info>
  <brief_title>Sutureless Cryopreserved Amniotic Membrane Graft (ProKera) and Wound Healing After Photorefractive Keratectomy</brief_title>
  <official_title>Sutureless Cryopreserved Amniotic Membrane Graft (ProKera) and Wound Healing After Photorefractive Keratectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Walter Reed National Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tissue Tech Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Ophthalmology and Optometry St John's Hospital and Clinics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Proteomics Shared Resource</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Walter Reed National Military Medical Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of ProKera on corneal wound healing after
      photorefractive keratectomy (PRK) in terms of re-epithelialization, pain, adverse effects,
      visual recovery, refractive accuracy, and corneal clarity.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Re-epithelialization</measure>
    <time_frame>participants will be followed daily until complete re-epithelialization, an expected average of 3-5 days post-operatively</time_frame>
    <description>measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Pain</measure>
    <time_frame>measured daily until complete re-epithelialization, an expected average of 3-5 days post-operatively</time_frame>
    <description>measured subjectively using the Visual Analog Scale (VAS) ranging from 0 (none) to 10 (worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications/Adverse Events</measure>
    <time_frame>one year post-operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Recovery</measure>
    <time_frame>one year post-operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term Visual Outcomes</measure>
    <time_frame>one year post-operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Clarity</measure>
    <time_frame>one year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tear Protein Analysis</measure>
    <time_frame>up to 1 month post-operatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Corneal Wound Healing</condition>
  <arm_group>
    <arm_group_label>ProKera</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bandage contact lens</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ProKera</intervention_name>
    <description>ProKera placed in non-dominant eye after PRK</description>
    <arm_group_label>ProKera</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bandage contact lens</intervention_name>
    <description>Bandage contact lens placed in dominant eye, the current standard after PRK</description>
    <arm_group_label>Bandage contact lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Active duty US Army Soldiers eligible for care at WRAMC.

          -  Male or female, of any race, and at least 21 years old at the time of the preoperative
             examination, and have signed and informed consent. The lower age limit of 21 years is
             intended to ensure documentation of refractive stability.

          -  Subject must expect to be located in the greater Washington DC area for a 12 month
             period post-operatively.

          -  Consent of the subject's command (active duty) to participate in the study.

          -  Access to transportation to meet follow-up requirements.

        Exclusion Criteria:

          -  Any reason to be excluded for PRK.

          -  Female subjects who are pregnant, breast-feeding or intend to become pregnant during
             the study. Female subjects will be give a urine pregnancy test prior to participating
             in the study to rule out pregnancy. [Pregnancy and breastfeeding are contraindications
             to refractive surgery in general, including PRK, whether participating in this study
             or not].

          -  Patients with known sensitivity or inappropriate responsiveness to any of the
             medications used in the post-operative course.

          -  Any physical or mental impairment that would preclude participation in any of the
             examinations.

          -  Anterior basement membrane dystrophy.

          -  History of recurrent epithelial erosion.

          -  Significant dry eye (symptomatic with Schirmer test &lt; 5 mm at 5 minutes).

          -  Other corneal epithelial disorder or healing abnormality.

          -  Patients with unusually tight eyelids close to the eyeball making it difficult and/ or
             painful to insert anything (e.g., ProKera) between the eyelid and globe.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard D Stutzman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WRNMMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Walter Reed Army Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2009</study_first_submitted>
  <study_first_submitted_qc>June 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2009</study_first_posted>
  <results_first_submitted>May 15, 2013</results_first_submitted>
  <results_first_submitted_qc>September 19, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 20, 2013</results_first_posted>
  <last_update_submitted>July 16, 2014</last_update_submitted>
  <last_update_submitted_qc>July 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fort Belvoir Community Hospital</investigator_affiliation>
    <investigator_full_name>Samanta B. Rodgers</investigator_full_name>
    <investigator_title>Assistant Research Director, Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir</investigator_title>
  </responsible_party>
  <keyword>ProKera</keyword>
  <keyword>Amniotic membrane</keyword>
  <keyword>Photorefractive Keratectomy</keyword>
  <keyword>PRK</keyword>
  <keyword>time to re-epithelialization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ProKera/Bandage Contact Lens</title>
          <description>Each patient received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40">number of participants</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40">number of participants</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ProKera and Bandage Contact Lens</title>
          <description>Each participant received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.1" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Corneal Re-epithelialization</title>
        <description>measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy</description>
        <time_frame>participants will be followed daily until complete re-epithelialization, an expected average of 3-5 days post-operatively</time_frame>
        <population>Each participant received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK. For group 1, ProKera and bandage contact lens were left in place until complete corneal re-repithelialization (healing).</population>
        <group_list>
          <group group_id="O1">
            <title>ProKera</title>
            <description>Group 1: ProKera in place until complete corneal re-repithelialization (healing)</description>
          </group>
          <group group_id="O2">
            <title>Bandage Contact Lens</title>
            <description>Group 1: bandage contact lens in place until complete corneal re-repithelialization (healing)</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Re-epithelialization</title>
          <description>measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy</description>
          <population>Each participant received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK. For group 1, ProKera and bandage contact lens were left in place until complete corneal re-repithelialization (healing).</population>
          <units>days to complete re-epithelialization</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" spread="1.6"/>
                    <measurement group_id="O2" value="4.1" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative Pain</title>
        <description>measured subjectively using the Visual Analog Scale (VAS) ranging from 0 (none) to 10 (worst possible pain)</description>
        <time_frame>measured daily until complete re-epithelialization, an expected average of 3-5 days post-operatively</time_frame>
        <posting_date>12/2013</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complications/Adverse Events</title>
        <time_frame>one year post-operatively</time_frame>
        <posting_date>12/2013</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Recovery</title>
        <time_frame>one year post-operatively</time_frame>
        <posting_date>12/2013</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Long-term Visual Outcomes</title>
        <time_frame>one year post-operatively</time_frame>
        <posting_date>12/2013</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Clarity</title>
        <time_frame>one year postoperatively</time_frame>
        <posting_date>12/2013</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tear Protein Analysis</title>
        <time_frame>up to 1 month post-operatively</time_frame>
        <posting_date>12/2013</posting_date>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Re-epithelialization</title>
        <description>measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy</description>
        <time_frame>participants will be followed daily until complete re-epithelialization, an expected average of 3-5 days post-operatively</time_frame>
        <population>Each participant received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK.For group 2, ProKera and bandage contact lens were left in place until postoperative day 3.</population>
        <group_list>
          <group group_id="O1">
            <title>ProKera</title>
            <description>Group 2: ProKera in place until postoperative day 3</description>
          </group>
          <group group_id="O2">
            <title>Bandage Contact Lens</title>
            <description>Group 2: bandage contact lens in place until postoperative day 3</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Re-epithelialization</title>
          <description>measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy</description>
          <population>Each participant received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK.For group 2, ProKera and bandage contact lens were left in place until postoperative day 3.</population>
          <units>days to complete re-epithelialization</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="3.5"/>
                    <measurement group_id="O2" value="3.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Re-epithelialization</title>
        <description>measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy</description>
        <time_frame>participants will be followed daily until complete re-epithelialization, an expected average of 3-5 days post-operatively</time_frame>
        <population>Each participant received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK.For group 3, ProKera and bandage contact lens were left in place until postoperative day 1.</population>
        <group_list>
          <group group_id="O1">
            <title>ProKera</title>
            <description>Group 3: ProKera in place until postoperative day 1</description>
          </group>
          <group group_id="O2">
            <title>Bandage Contact Lens</title>
            <description>Group 3: bandage contact lens in place until postoperative day 1</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Re-epithelialization</title>
          <description>measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy</description>
          <population>Each participant received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK.For group 3, ProKera and bandage contact lens were left in place until postoperative day 1.</population>
          <units>days to complete re-epithelialization</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="0.8"/>
                    <measurement group_id="O2" value="3.8" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>ProKera</title>
          <description>Each patient received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK</description>
        </group>
        <group group_id="E2">
          <title>Bandage Contact Lens</title>
          <description>Each patient received ProKera on dominant eye and bandage contact lens on fellow non-dominant eye after PRK</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Acute non-granulomatous anterior uveitis</sub_title>
                <description>Acute, non-granulomatous anterior uveitis is a common, idiopathic inflammatory process that afflicts the iris and ciliary body.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Principal Investigator</name_or_title>
      <organization>Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir</organization>
      <phone>571-231-1600</phone>
      <email>rose.sia@us.army.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

